Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 21737-58-6 | MDL No. : | MFCD00101078 |
Formula : | C14H11NO | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | VSZGCLXGCOECAY-UHFFFAOYSA-N |
M.W : | 209.24 | Pubchem ID : | 11160106 |
Synonyms : |
|
Chemical Name : | 5H-Dibenzo[b,f]azepin-10(11H)-one |
Num. heavy atoms : | 16 |
Num. arom. heavy atoms : | 12 |
Fraction Csp3 : | 0.07 |
Num. rotatable bonds : | 0 |
Num. H-bond acceptors : | 1.0 |
Num. H-bond donors : | 1.0 |
Molar Refractivity : | 67.16 |
TPSA : | 29.1 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | Yes |
CYP1A2 inhibitor : | Yes |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | Yes |
Log Kp (skin permeation) : | -5.51 cm/s |
Log Po/w (iLOGP) : | 2.03 |
Log Po/w (XLOGP3) : | 2.91 |
Log Po/w (WLOGP) : | 2.79 |
Log Po/w (MLOGP) : | 2.48 |
Log Po/w (SILICOS-IT) : | 3.19 |
Consensus Log Po/w : | 2.68 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 0.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -3.53 |
Solubility : | 0.0624 mg/ml ; 0.000298 mol/l |
Class : | Soluble |
Log S (Ali) : | -3.18 |
Solubility : | 0.138 mg/ml ; 0.000658 mol/l |
Class : | Soluble |
Log S (SILICOS-IT) : | -5.41 |
Solubility : | 0.00081 mg/ml ; 0.00000387 mol/l |
Class : | Moderately soluble |
PAINS : | 0.0 alert |
Brenk : | 0.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 2.47 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H319 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
89% | With sodium tetrahydroborate In methanol; water at 45℃; for 1 h; | 5H-dibenzo[b,f]azepin-10(11H)-one 6 (350.0 g, 1.67 mol) was suspended in a mixture of water (0.7 L) and methanol (2.8 L), sodium borohydride (76 g, 2.0 mol) was added in portions over 10 min without cooling, and stirring continued at 45 °C for 1 h. Acetone (350 mL) was added cautiously, and the reaction mixture was evaporated down to a small volume. Addition of water (700 mL) precipitated the product (315 g, 89percent) and dried at 60-65˚C to give the (S)-10,11-dihydro-5H-dibenzo[b,f]azepin-10-ol 7b as an off-white solid (315 g) in 89.0percent yield and >98percent purity |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
4) Potassium tert-butoxide (3.1 g) and water (153 mul) were added to a tetrahydrofuran (20 ml) solution of the compound (1.01 g) obtained in 3), and the solution was stirred at 80 C. for 1.5 hours under heating. The solution was allowed to cool and poured into water, followed by extraction with ethyl acetate. The organic phase was washed with water and saturated brine, dried over anhydrous sodium sulfate, and filtered. The filtrate was concentrated and the resulting residue was purified by silica gel column chromatography (developing solvent, ethyl acetate: hexane=1:5) to obtain 10,11-dihydro-10-oxo-5H-dibenzo[b,f]azepine (624 mg; yield, 69%) as a yellow solid. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
93% | In dichloromethane; at 0 - 5℃;Inert atmosphere; | To a solution of azepine-10-One (25 g, 0.119 mol) in Dichloromethane (200 ml) was dropwise added the solution of chloro sulphonyl isocyanate (32.6g, 0.230 mol) in Dichloromethane (100 ml) under nitrogen atmosphere at 0-5 C. After the addition of chloro sulphonyl isocyanate, reaction mixture was stirred for 1-2 hrs at 0-5 C. The Progress of reaction was monitored by TLC. Reaction mixture was quenched with Glacial acetic acid (25 ml) followed by addition of DM water (150 ml) at 10-15 C. Layers were separated and Aq. layer was re-extracted with Dichloromethane (3*200 ml). Combined Dichloromethane layer was distilled off at reduced pressure at 40-45 C. Product was further crystallized with Isopropyl alcohol (100 ml) to get pure azepine amide (27.90 g, 93%) with 98.52% Purity by HPLC. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
97% | In dichloromethane; at 0 - 10℃; | EXAMPLE 2; Preparation of 10-Oxo-10,11-dihydro-5H-dibenz[b,f]azepin-5-carboxamide III; A 1-L, three-necked flask equipped with a thermometer, nitrogen inlet, mechanical stirrer and addition funnel, was charged with oximinostilbene IV (prepared above) followed by 400 mL dichloromethane. The suspension was cooled to 0-5 C. and a solution of chlorosulfonyl isocyanate (71.7 g, 0.50 mol) in 200 mL dichloromethane was added dropwise, maintaining the internal temperature at 0-10 C. Following the addition, the reaction mixture was maintained at 0-5 C. until reaction completion. The cold suspension was then filtered and washed giving oxcarbazepine intermediate V (163 g, 97%). The damp solid was suspended in 300 ml glacial acetic acid and cooled to 10-15 C. To the suspension was added 188 mL cold water, portionwise, maintaining the IT<20 C. The mixture was maintained at 15-25 C. for 0.5-1.0 h until reaction completion. The suspension was concentrated to 200-300 ml and 700 mL isopropanol was added to precipitate the product. The suspension was then filtered and washed. The damp cake was purified in an isopropanol:water mixture to furnish oxcarbazepine as a white to off-white solid (101.27 g, 84%, purity of 99.5% by HPLC). 1H NMR (DMSO, d): 4.06, 6.19, 7.30-7.39, 7.44-7.51, 7.63, 7.91 ppm. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
97% | With hydrogenchloride; water; In acetone; at 20℃; for 1 - 1.5h; | EXAMPLE I; Preparation of 5,11-Dihydro-10H-dibenz[b,f]azepine-10-one (Oximinostilbene) IV; A 2-L, three-necked flask equipped with a mechanical stirrer, thermometer and nitrogen inlet was charged with 10-methoxyiminostilbene I (110.0 g, 0.49 mol) and 330 mL acetone. A 10% solution of hydrochloric acid (28.6 g, 0.08 mol) was then added. The reaction mixture was stirred at ambient temperature for 1-1.5 hours until reaction completion. The product was precipitated by the addition of 660 mL of deionized water, and the resulting suspension was stirred for 3-4 hours. The suspension was filtered and washed with water. After drying, oximinostilbene (99.92 g, 97%) was obtained as a bright yellow solid having a purity of 99% by HPLC. 1H NMR (CDCl3, d): 3.80, 6.87, 7.04-7.15, 7.22-7.24, 7.32-7.37, 8.04 ppm. |
85.4% | With hydrogenchloride; In water; isopropyl alcohol; at 25 - 65℃; | 10-Methoxy-5H-dibenzo[b,f]azepine 4 (500 g, 2.23 mol) and isopropanol (1.0 L) were charged into a round bottomed flask and stirred for 5-10 min. 50% Aqueous hydrochloride solution (250 mL) was then added slowly to the mixture at 25-35 ?C and stirred for 15 min. The reaction mixture was heated to 60-65 ?C and maintained for 2-3 h. The progress of the reaction was monitored by TLC, and after completion of the reaction (by TLC), ethyl acetate (1.5 L) and water (1.0 L) were added into the reaction mixture and stirred for 5-10 min. Organic layer was separated and the aqueous layer was extracted with ethyl acetate (1.5 L). The combined organic layer was washed with 5% caustic lye solution (500 mL) followed by 10 % NaCl solution (500 mL) and evaporated at 50-55?C under reduced pressure. n-Hexane (500 mL) was then added into the crude product at 25-30 ?C and stirred for 1-2 h. The obtained solid was collected by filtration, washed with n-hexane (250 mL) and dried at 60-65 ?C to afford the title compound 6 as yellow solid (400 g) in 85.4% yield and >98.2% purity. Spectroscopic data were found to be in agreement with the data collected from authentic sample of intermediate 6. IR (KBR): 3329, 3284, 3040, 1643, 1474, 1309, 753 cm-1; 1H NMR (400 MHz, CDCl3): delta 3.72 (2H, s), 6.78-7.91 (8H, m); 13C NMR (400 MHz, CDCl3): delta 49.4, 119.1, 119.2, 119.8, 124.1, 124.5, 127.7, 127.9, 129.8, 130.3, 133.7, 141.5, 146.8, 190.1; HRMS calcd for C14H11NO, 210.0919; found 210.0909. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With hydrogenchloride; In ethanol; toluene; | EXAMPLE 11 10-oxo-10,11-dihydro-5H-dibenz(b,f)azepine 22.3 g of 10-methoxy-5H-dibenz(b,f)azepine are heated under reflux with 100 ml of 2N hydrochloric acid for 2 hours. The gummy residue is extracted with chloroform (50÷50 ml), the combined extracts are washed with water and evaporated to dryness under vacuum. The residue is taken up into 200 ml of ethanol, treated with charcoal (2 g) for 1 h under reflux, filtered, evaporated to dryness under vacuum, finally taken up into 50÷50 ml of toluene, stripping thoroughly. The residue is kept for further working-up. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With [iridium(dihydride)(chloride)((3,5-(tBu)2-C6H3)2P)(C17H10)NHCHC5H3N(CH3)]; hydrogen; potassium carbonate; In butan-1-ol; at 25℃; under 13501.4 - 15001.5 Torr;Autoclave; | Under nitrogen protection,Weigh 1.0mg (0.001mmol) of chiral catalyst C1 (X is 6-methyl),13.8mg (0.1mmol) potassium carbonateAnd 418.6 mg (2 mmol) of <strong>[21737-58-6]5,11-dihydro-10H-dibenzo[b,f]azepin-10-one</strong> into the reaction tube,Add 6mL of n-butanol to the inner tube of the reaction,Put the reaction tube into the autoclave,The gas in the kettle was replaced with hydrogen to maintain the hydrogen pressure at 1.8 to 2.0 MPa, and the reaction was stirred at 25 C until the hydrogen pressure did not decrease and the reaction was stopped.The reaction solution was concentrated. 10 mL of water and 10 mL of ethyl acetate were added to the system, and the layers were separated. The aqueous phase was extracted twice more with ethyl acetate (10 mL x 2), and the organic phases were combined, washed once with saturated brine, and dried over anhydrous sodium sulfate.Suction filtration, spin-drying the solvent to obtain (S)-5,11-dihydro-10H-dibenzo[b,f]azepin-10-ol 266mg, yield 63%According to NMR analysis, the raw material 5,11-dihydro-10H-dibenzo [b, f] aza-10-one has not been completely converted.The product was analyzed by chiral HPLC and its optical purity was 88.1% ee. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
96% | With [iridium(dihydride)(chloride)((3,5-(tBu)2-C6H3)2P)(C17H10)NHCHC5H3N(CH3)]; potassium tert-butylate; hydrogen; In butan-1-ol; at 25℃; under 13501.4 - 15001.5 Torr;Autoclave; | Under nitrogen protection,Weigh 1.0mg (0.001mmol) of chiral catalyst C1 (X is 6-methyl),11.2 mg (0.1 mmol) of potassium tert-butoxide and418.6mg (2mmol) of <strong>[21737-58-6]5,11-dihydro-10H-dibenzo[b,f]azepin-10-one</strong> into the inner tube of the reaction,Add 6 mL of n-butanol to the inner tube of the reaction.Put the reaction tube into the autoclave,Replace the gas in the kettle with hydrogen,Keep the hydrogen pressure at 1.8 2.0MPa,The reaction vessel was stirred at 25 C until the hydrogen pressure did not drop any more, and the reaction was stopped.The reaction solution was concentrated.10 mL of water and 10 mL of ethyl acetate were added to the system, and the layers were separated.The aqueous phase was extracted twice more with ethyl acetate (10 mL x 2), and the organic phases were combined.Wash again with saturated saline and dry over anhydrous sodium sulfate.Suction filtration,The solvent was spin-dried to obtain 406 mg of (S)-5,11-dihydro-10H-dibenzo[b,f]azepin-10-ol, with a yield of 96%.According to NMR analysis, the conversion of 5,11-dihydro-10H-dibenzo [b, f] aza-10-one was complete.The product was analyzed by chiral HPLC and its optical purity was 99.2% ee. |
91% | With dimethylsulfide borane complex; (3aR)-1-methyl-3,3-diphenyl-tetrahydro-pyrrolo[1,2-c][1,3,2]oxazaborole; In dichloromethane; toluene; at -5 - 10℃; | Dichloromethane (1.0 L) and borane dimethyl sulfide (216 mL, 2.17 mol) were charged into a round bottomed flask and stirred for 10 min, and was cooled to -5-0?C. R-2-Me-CBS (methyl oxazaborolidine, 1M in toluene) (335 mL, 0.33 mol) was then added to the reaction flask at -5-0?C and stirred for 10 min. A solution of <strong>[21737-58-6]5H-dibenzo[b,f]azepin-10(11H)-one</strong> 6 (350.0 g, 1.67 mol) in dichloromethane (1.75 L) was added to the reaction mixture. The reaction mixture was warmed to 0-10?C and maintained for 3-4 h at the same temperature. The reaction was monitored by TLC, and after completion of the reaction, methanol (140.0 mL), 5% H2O2 (700 mL) solution and 2N H2SO4 solution (700 mL) were added to the reaction mixture and stirred for 15-20 min. The organic layer was separated and washed with 5 % Na2SO3 solution (875 mL), followed by 10 % NaCl solution (875 mL). The solvent was evaporated at 35-40 ?C under reduced pressure. Water (700.0 mL) was added to the crude product thus obtained at 25-30?C and stirred for 1 h. The product was filtered off, washed with water (350 mL) and dried at 60-65?C to give the (S)(-)-10,11-dihydro-5H-dibenzo[b,f]azepin-10-ol 7a as an off-white solid (321.7 g) in 91% yield and >98.5% purity. Spectroscopic data were found to be in agreement with the data collected from authentic sample of intermediate 7a. 99 % ee. [alpha]D25: -38.5 (c =1, Chloroform); IR (KBR): 3504, 3308, 2937, 1589, 1485, 1331, 762 cm-1; 1H NMR (400 MHz, CDCl3): delta 1.74 (1H, s), 3.09-3.19 (2H, m), 5.02 (1H, m), 6.02 (1H, s), 6.66-7.25 (8H, m); 13C NMR (400 MHz, CDCl3): delta 40.1, 71.7, 117.6, 118.6, 120.1, 121.2, 124.2, 127.6, 128.5, 128.6, 131.5, 131.8, 141.5, 142.9; HRMS calcd for C14H13NO, 212.1075; found 212.1084 |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
89% | With sodium tetrahydroborate; In methanol; water; at 45℃; for 1h; | <strong>[21737-58-6]5H-dibenzo[b,f]azepin-10(11H)-one</strong> 6 (350.0 g, 1.67 mol) was suspended in a mixture of water (0.7 L) and methanol (2.8 L), sodium borohydride (76 g, 2.0 mol) was added in portions over 10 min without cooling, and stirring continued at 45 C for 1 h. Acetone (350 mL) was added cautiously, and the reaction mixture was evaporated down to a small volume. Addition of water (700 mL) precipitated the product (315 g, 89%) and dried at 60-65?C to give the (S)-10,11-dihydro-5H-dibenzo[b,f]azepin-10-ol 7b as an off-white solid (315 g) in 89.0% yield and >98% purity |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
90% | With potassium hydroxide; In ethylene glycol; at 200℃; for 6h;Inert atmosphere; | Under a nitrogen stream,Preparation Example 1,step 3,5-acetyl-5H-dibenzo[b,f]azepin-10 (11H)-one (70.5 g, 280.7mmol), potassium hydroxide (17.3 g, 308.7 mmol) and ethylene glycol (700 ml), and a mixture was stirred at 200C for 6 hours. After the reaction was terminated by the removal of water and the organic layer extracted with ethyl acetate and MgSO4, and purified by column chromatography(Hexane EA = 6:1 (v / v)) to give 5H-dibenzo[b,f]azepin-10(11H)-one (52.9 g, yield 90%). |
90% | With potassium hydroxide; In 1,2-dimethoxyethane; at 200℃; for 6h;Inert atmosphere; | Preparation Example 1 Under a nitrogen streamof obtained from 5-acetyl-5H-dibenzo [b, f] azepin-10 (11H)-one(70.5 g, 280.7 mmol), potassium hydroxide (17.3 g, 308.7 mmol ) and ethyleneglycol (700 ml and the mixture), was stirred at 200 C for 6 hours.The reaction was terminated, and then removingwater to extract the organic layer with ethyl acetate and MgSO4, and purifiedby column chromatography (Hexane: EA = 6: 1 (v / v)) to give 5H-dibenzo [b, f]azepin-10 in (11H) -one to give a (52.9 g, yield 90%). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
73% | With acetic acid; at 120℃; for 12h;Inert atmosphere; | under a nitrogen stream, preparation example 1,step 4 compound, <strong>[21737-58-6]5H-dibenzo[b,f]azepin-10(11H)-one</strong> (52.9 g, 252.6 mmol) and N,N-diphenylhydrazine (51.2 g, 277.9 mmol), and insert the acetic acid (500 ml), was stirred for 12 hours at 120C. After the reaction the organic layer was extracted with dichloromethane, and filtered into the MgSO4. Removing the solvent from the resulting organic layer after column chromatography (Hexane MC = 4:1 (v / v)) to obtain the compound 1-IAz (66.1 g, yield 73%). |
73% | With acetic acid; at 120℃; for 12h;Inert atmosphere; | Under a stream of nitrogen 5H-dibenzo [b, f] azepin-10 (11H)-one (52.9 g, 252.6 mmol), N, N-diphenylhydrazine (51.2g, 277.9 mmol) and acetic acid (500 ml) and the mixture 120 in it was stirred for 12 hours. After the reaction was terminated by extraction with dichloromethane and filtered into a MgSO4. After removal of the solvent from the obtained organic layer was purified by column chromatography (Hexane: MC = 4: 1 (v / v)) was obtained to give the compound I-1 (66.1 g, yield 73%) as a. |
73% | With acetic acid; at 120℃; for 12h;Inert atmosphere; | Preparation Example 1 Under a nitrogen gas stream in the obtainedin the 5H-dibenzo [b, f] azepin-10 (11H)-one (52.9 g, 252.6 mmol) and N,N-diphenylhydrazine (51.2 g, 277.9 mmol) , and after inserting the acetic acid(500 ml), it was stirred for 12 hours at 120 C After the reaction the organic layer was extractedwith dichloromethane, and filtered into the MgSO4. After removal of the solventfrom the obtained organic layer was purified by column chromatography (Hexane:MC = 4: 1 (v / v)) to obtain to obtain the compound 1-IAz (66.1 g, yield 73%)as a. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
72% | With copper; potassium carbonate; In nitrobenzene; at 210℃; for 12h;Inert atmosphere; | Under a stream of nitrogen 5H-dibenzo [b, f] azepin-10 (11H)-one (100 g, 477.9 mmol), iodobenzene (117 g, 573.5mmol), Cu (15.18 g, 238.9 mmol), K2CO3 (132.1 g, mixing 955.8 mmol), and nitrobenzene (1000 ml) and stirred for 12 hours at 210 . The reaction was terminated and extracted with ethyl acetate, concentrated and recrystallized with ethanol, 5-phenyl-5H-dibenzo [b, f] azepin-10 (11H) -one to give a (98.18 g, 72% yield). |
Tags: 21737-58-6 synthesis path| 21737-58-6 SDS| 21737-58-6 COA| 21737-58-6 purity| 21737-58-6 application| 21737-58-6 NMR| 21737-58-6 COA| 21737-58-6 structure
[ 1859-75-2 ]
1-(2-(Methylamino)phenyl)ethanone
Similarity: 0.92
[ 16619-14-0 ]
2-Phenyl-2,3-dihydroquinolin-4(1H)-one
Similarity: 0.89
[ 113961-88-9 ]
1-(1,2,3,4-Tetrahydroquinolin-6-yl)ethanone
Similarity: 0.89
[ 15128-52-6 ]
2,3-Dihydro-1H-carbazol-4(9H)-one
Similarity: 0.86
[ 1143-50-6 ]
5H-Dibenzo[b,e]azepine-6,11-dione
Similarity: 0.85
[ 27387-31-1 ]
1,2,3,9-Tetrahydro-9-methyl-4H-carbazole-4-one
Similarity: 0.82
[ 3449-48-7 ]
6-Methyl-2,3,4,9-tetrahydro-1H-carbazol-1-one
Similarity: 0.81
Precautionary Statements-General | |
Code | Phrase |
P101 | If medical advice is needed,have product container or label at hand. |
P102 | Keep out of reach of children. |
P103 | Read label before use |
Prevention | |
Code | Phrase |
P201 | Obtain special instructions before use. |
P202 | Do not handle until all safety precautions have been read and understood. |
P210 | Keep away from heat/sparks/open flames/hot surfaces. - No smoking. |
P211 | Do not spray on an open flame or other ignition source. |
P220 | Keep/Store away from clothing/combustible materials. |
P221 | Take any precaution to avoid mixing with combustibles |
P222 | Do not allow contact with air. |
P223 | Keep away from any possible contact with water, because of violent reaction and possible flash fire. |
P230 | Keep wetted |
P231 | Handle under inert gas. |
P232 | Protect from moisture. |
P233 | Keep container tightly closed. |
P234 | Keep only in original container. |
P235 | Keep cool |
P240 | Ground/bond container and receiving equipment. |
P241 | Use explosion-proof electrical/ventilating/lighting/equipment. |
P242 | Use only non-sparking tools. |
P243 | Take precautionary measures against static discharge. |
P244 | Keep reduction valves free from grease and oil. |
P250 | Do not subject to grinding/shock/friction. |
P251 | Pressurized container: Do not pierce or burn, even after use. |
P260 | Do not breathe dust/fume/gas/mist/vapours/spray. |
P261 | Avoid breathing dust/fume/gas/mist/vapours/spray. |
P262 | Do not get in eyes, on skin, or on clothing. |
P263 | Avoid contact during pregnancy/while nursing. |
P264 | Wash hands thoroughly after handling. |
P265 | Wash skin thouroughly after handling. |
P270 | Do not eat, drink or smoke when using this product. |
P271 | Use only outdoors or in a well-ventilated area. |
P272 | Contaminated work clothing should not be allowed out of the workplace. |
P273 | Avoid release to the environment. |
P280 | Wear protective gloves/protective clothing/eye protection/face protection. |
P281 | Use personal protective equipment as required. |
P282 | Wear cold insulating gloves/face shield/eye protection. |
P283 | Wear fire/flame resistant/retardant clothing. |
P284 | Wear respiratory protection. |
P285 | In case of inadequate ventilation wear respiratory protection. |
P231 + P232 | Handle under inert gas. Protect from moisture. |
P235 + P410 | Keep cool. Protect from sunlight. |
Response | |
Code | Phrase |
P301 | IF SWALLOWED: |
P304 | IF INHALED: |
P305 | IF IN EYES: |
P306 | IF ON CLOTHING: |
P307 | IF exposed: |
P308 | IF exposed or concerned: |
P309 | IF exposed or if you feel unwell: |
P310 | Immediately call a POISON CENTER or doctor/physician. |
P311 | Call a POISON CENTER or doctor/physician. |
P312 | Call a POISON CENTER or doctor/physician if you feel unwell. |
P313 | Get medical advice/attention. |
P314 | Get medical advice/attention if you feel unwell. |
P315 | Get immediate medical advice/attention. |
P320 | |
P302 + P352 | IF ON SKIN: wash with plenty of soap and water. |
P321 | |
P322 | |
P330 | Rinse mouth. |
P331 | Do NOT induce vomiting. |
P332 | IF SKIN irritation occurs: |
P333 | If skin irritation or rash occurs: |
P334 | Immerse in cool water/wrap n wet bandages. |
P335 | Brush off loose particles from skin. |
P336 | Thaw frosted parts with lukewarm water. Do not rub affected area. |
P337 | If eye irritation persists: |
P338 | Remove contact lenses, if present and easy to do. Continue rinsing. |
P340 | Remove victim to fresh air and keep at rest in a position comfortable for breathing. |
P341 | If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing. |
P342 | If experiencing respiratory symptoms: |
P350 | Gently wash with plenty of soap and water. |
P351 | Rinse cautiously with water for several minutes. |
P352 | Wash with plenty of soap and water. |
P353 | Rinse skin with water/shower. |
P360 | Rinse immediately contaminated clothing and skin with plenty of water before removing clothes. |
P361 | Remove/Take off immediately all contaminated clothing. |
P362 | Take off contaminated clothing and wash before reuse. |
P363 | Wash contaminated clothing before reuse. |
P370 | In case of fire: |
P371 | In case of major fire and large quantities: |
P372 | Explosion risk in case of fire. |
P373 | DO NOT fight fire when fire reaches explosives. |
P374 | Fight fire with normal precautions from a reasonable distance. |
P376 | Stop leak if safe to do so. Oxidising gases (section 2.4) 1 |
P377 | Leaking gas fire: Do not extinguish, unless leak can be stopped safely. |
P378 | |
P380 | Evacuate area. |
P381 | Eliminate all ignition sources if safe to do so. |
P390 | Absorb spillage to prevent material damage. |
P391 | Collect spillage. Hazardous to the aquatic environment |
P301 + P310 | IF SWALLOWED: Immediately call a POISON CENTER or doctor/physician. |
P301 + P312 | IF SWALLOWED: call a POISON CENTER or doctor/physician IF you feel unwell. |
P301 + P330 + P331 | IF SWALLOWED: Rinse mouth. Do NOT induce vomiting. |
P302 + P334 | IF ON SKIN: Immerse in cool water/wrap in wet bandages. |
P302 + P350 | IF ON SKIN: Gently wash with plenty of soap and water. |
P303 + P361 + P353 | IF ON SKIN (or hair): Remove/Take off Immediately all contaminated clothing. Rinse SKIN with water/shower. |
P304 + P312 | IF INHALED: Call a POISON CENTER or doctor/physician if you feel unwell. |
P304 + P340 | IF INHALED: Remove victim to fresh air and Keep at rest in a position comfortable for breathing. |
P304 + P341 | IF INHALED: If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing. |
P305 + P351 + P338 | IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. |
P306 + P360 | IF ON CLOTHING: Rinse Immediately contaminated CLOTHING and SKIN with plenty of water before removing clothes. |
P307 + P311 | IF exposed: call a POISON CENTER or doctor/physician. |
P308 + P313 | IF exposed or concerned: Get medical advice/attention. |
P309 + P311 | IF exposed or if you feel unwell: call a POISON CENTER or doctor/physician. |
P332 + P313 | IF SKIN irritation occurs: Get medical advice/attention. |
P333 + P313 | IF SKIN irritation or rash occurs: Get medical advice/attention. |
P335 + P334 | Brush off loose particles from skin. Immerse in cool water/wrap in wet bandages. |
P337 + P313 | IF eye irritation persists: Get medical advice/attention. |
P342 + P311 | IF experiencing respiratory symptoms: call a POISON CENTER or doctor/physician. |
P370 + P376 | In case of fire: Stop leak if safe to Do so. |
P370 + P378 | In case of fire: |
P370 + P380 | In case of fire: Evacuate area. |
P370 + P380 + P375 | In case of fire: Evacuate area. Fight fire remotely due to the risk of explosion. |
P371 + P380 + P375 | In case of major fire and large quantities: Evacuate area. Fight fire remotely due to the risk of explosion. |
Storage | |
Code | Phrase |
P401 | |
P402 | Store in a dry place. |
P403 | Store in a well-ventilated place. |
P404 | Store in a closed container. |
P405 | Store locked up. |
P406 | Store in corrosive resistant/ container with a resistant inner liner. |
P407 | Maintain air gap between stacks/pallets. |
P410 | Protect from sunlight. |
P411 | |
P412 | Do not expose to temperatures exceeding 50 oC/ 122 oF. |
P413 | |
P420 | Store away from other materials. |
P422 | |
P402 + P404 | Store in a dry place. Store in a closed container. |
P403 + P233 | Store in a well-ventilated place. Keep container tightly closed. |
P403 + P235 | Store in a well-ventilated place. Keep cool. |
P410 + P403 | Protect from sunlight. Store in a well-ventilated place. |
P410 + P412 | Protect from sunlight. Do not expose to temperatures exceeding 50 oC/122oF. |
P411 + P235 | Keep cool. |
Disposal | |
Code | Phrase |
P501 | Dispose of contents/container to ... |
P502 | Refer to manufacturer/supplier for information on recovery/recycling |
Physical hazards | |
Code | Phrase |
H200 | Unstable explosive |
H201 | Explosive; mass explosion hazard |
H202 | Explosive; severe projection hazard |
H203 | Explosive; fire, blast or projection hazard |
H204 | Fire or projection hazard |
H205 | May mass explode in fire |
H220 | Extremely flammable gas |
H221 | Flammable gas |
H222 | Extremely flammable aerosol |
H223 | Flammable aerosol |
H224 | Extremely flammable liquid and vapour |
H225 | Highly flammable liquid and vapour |
H226 | Flammable liquid and vapour |
H227 | Combustible liquid |
H228 | Flammable solid |
H229 | Pressurized container: may burst if heated |
H230 | May react explosively even in the absence of air |
H231 | May react explosively even in the absence of air at elevated pressure and/or temperature |
H240 | Heating may cause an explosion |
H241 | Heating may cause a fire or explosion |
H242 | Heating may cause a fire |
H250 | Catches fire spontaneously if exposed to air |
H251 | Self-heating; may catch fire |
H252 | Self-heating in large quantities; may catch fire |
H260 | In contact with water releases flammable gases which may ignite spontaneously |
H261 | In contact with water releases flammable gas |
H270 | May cause or intensify fire; oxidizer |
H271 | May cause fire or explosion; strong oxidizer |
H272 | May intensify fire; oxidizer |
H280 | Contains gas under pressure; may explode if heated |
H281 | Contains refrigerated gas; may cause cryogenic burns or injury |
H290 | May be corrosive to metals |
Health hazards | |
Code | Phrase |
H300 | Fatal if swallowed |
H301 | Toxic if swallowed |
H302 | Harmful if swallowed |
H303 | May be harmful if swallowed |
H304 | May be fatal if swallowed and enters airways |
H305 | May be harmful if swallowed and enters airways |
H310 | Fatal in contact with skin |
H311 | Toxic in contact with skin |
H312 | Harmful in contact with skin |
H313 | May be harmful in contact with skin |
H314 | Causes severe skin burns and eye damage |
H315 | Causes skin irritation |
H316 | Causes mild skin irritation |
H317 | May cause an allergic skin reaction |
H318 | Causes serious eye damage |
H319 | Causes serious eye irritation |
H320 | Causes eye irritation |
H330 | Fatal if inhaled |
H331 | Toxic if inhaled |
H332 | Harmful if inhaled |
H333 | May be harmful if inhaled |
H334 | May cause allergy or asthma symptoms or breathing difficulties if inhaled |
H335 | May cause respiratory irritation |
H336 | May cause drowsiness or dizziness |
H340 | May cause genetic defects |
H341 | Suspected of causing genetic defects |
H350 | May cause cancer |
H351 | Suspected of causing cancer |
H360 | May damage fertility or the unborn child |
H361 | Suspected of damaging fertility or the unborn child |
H361d | Suspected of damaging the unborn child |
H362 | May cause harm to breast-fed children |
H370 | Causes damage to organs |
H371 | May cause damage to organs |
H372 | Causes damage to organs through prolonged or repeated exposure |
H373 | May cause damage to organs through prolonged or repeated exposure |
Environmental hazards | |
Code | Phrase |
H400 | Very toxic to aquatic life |
H401 | Toxic to aquatic life |
H402 | Harmful to aquatic life |
H410 | Very toxic to aquatic life with long-lasting effects |
H411 | Toxic to aquatic life with long-lasting effects |
H412 | Harmful to aquatic life with long-lasting effects |
H413 | May cause long-lasting harmful effects to aquatic life |
H420 | Harms public health and the environment by destroying ozone in the upper atmosphere |
Sorry,this product has been discontinued.
Home
* Country/Region
* Quantity Required :
* Cat. No.:
* CAS No :
* Product Name :
* Additional Information :